OTC Markets OTCPK - Delayed Quote • USD
Humanigen, Inc. (HGENQ)
At close: May 16 at 1:27 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,699.0000
2,514.0000
3,595.0000
312.0000
--
Operating Expense
53,709.0000
70,818.0000
236,367.0000
88,510.0000
8,944.0000
Operating Income
-52,010.0000
-68,304.0000
-232,772.0000
-88,198.0000
-8,944.0000
Net Non Operating Interest Income Expense
-2,202.0000
-2,918.0000
-2,264.0000
-1,336.0000
-1,349.0000
Other Income Expense
578.0000
492.0000
-1,613.0000
-1.0000
-1.0000
Pretax Income
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Net Income Common Stockholders
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Diluted NI Available to Com Stockholders
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Basic EPS
-0.51
-0.79
-4.04
-2.42
-0.46
Diluted EPS
-0.51
-0.79
-4.04
-2.42
-0.46
Basic Average Shares
102,608.7820
89,236.4290
58,533.6370
36,963.0300
22,361.2500
Diluted Average Shares
102,608.7820
89,236.4290
58,533.6370
36,963.0300
22,361.2500
Total Operating Income as Reported
-52,010.0000
-68,304.0000
-232,772.0000
-88,198.0000
-8,944.0000
Total Expenses
53,709.0000
70,818.0000
236,367.0000
88,510.0000
8,944.0000
Net Income from Continuing & Discontinued Operation
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Normalized Income
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Interest Expense
2,202.0000
2,918.0000
2,264.0000
1,336.0000
1,349.0000
Net Interest Income
-2,202.0000
-2,918.0000
-2,264.0000
-1,336.0000
-1,349.0000
EBIT
-51,432.0000
-67,812.0000
-234,385.0000
-88,199.0000
-8,945.0000
EBITDA
-51,432.0000
-67,812.0000
-234,385.0000
-88,199.0000
-8,945.0000
Net Income from Continuing Operation Net Minority Interest
-53,634.0000
-70,730.0000
-236,649.0000
-89,535.0000
-10,294.0000
Normalized EBITDA
-51,432.0000
-67,812.0000
-234,385.0000
-88,199.0000
-8,945.0000
12/31/2019 - 1/31/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLSHQ Gelesis Holdings, Inc.
0.0000
-99.99%
SNBIF SanBio Company Limited
3.8500
+1.32%
ATHXQ Athersys, Inc.
0.0031
-27.06%
SNBOY SanBio Company Limited
2.8100
-38.24%
MRZM Marizyme, Inc.
0.0533
0.00%
SQZB SQZ Biotechnologies Company
0.0350
-22.22%
EIGRQ Eiger BioPharmaceuticals, Inc.
2.2900
+1.33%
IPCIF Intellipharmaceutics International Inc.
0.0258
0.00%
OBD.L Oxford BioDynamics Plc
7.85
-0.63%
RVLPQ RVL Pharmaceuticals plc
0.0001
-80.00%